14.71
price down icon1.34%   -0.20
after-market Dopo l'orario di chiusura: 14.80 0.09 +0.61%
loading

Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
4.15%
45.88
47.86 34.87 36.77 37.62
Operating Income/Loss
4.15%
-45.88
-47.86 -34.87 -36.77 -37.62
Nonoperating Income/Loss
10.29%
3.66
4.08 4.484 3.201 3.066
Income/Loss From Continuing Operations Before Tax
3.58%
-42.22
-43.78 -30.39 -33.56 -34.55
Income/Loss From Continuing Operations After Tax
3.58%
-42.22
-43.78 -30.39 -33.57 -34.55
Net Income/Loss
3.58%
-42.22
-43.78 -30.39 -33.57 -34.55
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
85.73
85.50 85.43 5.5494 57.26
Diluted Average Shares
0.27%
85.73
85.50 85.43 5.5494 57.26
Basic Earnings Per Share
3.92%
-0.49
-0.51 -0.36 -0.40 -0.60
Diluted Earnings Per Share
3.92%
-0.49
-0.51 -0.36 -0.40 -0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):